Solid Tumor Clinical Trials

104 studies are recruiting for solid tumor in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Houston, Texas 36 New York, New York 33 Boston, Massachusetts 25 Nashville, Tennessee 25 Fairfax, Virginia 21 San Antonio, Texas 19 Los Angeles, California 18 Dallas, Texas 17 Chicago, Illinois 16 St Louis, Missouri 16 San Francisco, California 13 Portland, Oregon 12 Philadelphia, Pennsylvania 11 Cleveland, Ohio 10 Denver, Colorado 10 Detroit, Michigan 10 Grand Rapids, Michigan 10 New Haven, Connecticut 10 Pittsburgh, Pennsylvania 10 Atlanta, Georgia 9 Jacksonville, Florida 9 Rochester, Minnesota 9 Scottsdale, Arizona 9 Tampa, Florida 9 Washington D.C., District of Columbia 9 Aurora, Colorado 8 Duarte, California 8 Durham, North Carolina 8 Hackensack, New Jersey 8 Orlando, Florida 8 Miami, Florida 7 Phoenix, Arizona 7 Santa Monica, California 7 Seattle, Washington 7 West Valley City, Utah 7 Iowa City, Iowa 6 Milwaukee, Wisconsin 6 Tyler, Texas 6 Basking Ridge, New Jersey 5 Charlottesville, Virginia 5 Cincinnati, Ohio 5 Columbus, Ohio 5 Commack, New York 5 Harrison, New York 5 Irving, Texas 5 Lake Mary, Florida 5 Middletown, New Jersey 5 Minneapolis, Minnesota 5 Montvale, New Jersey 5 Palo Alto, California 5 Salt Lake City, Utah 5 The Bronx, New York 5 Augusta, Georgia 4 Austin, Texas 4 Baltimore, Maryland 4 Bethesda, Maryland 4 Buffalo, New York 4 La Jolla, California 4 Oklahoma City, Oklahoma 4 Omaha, Nebraska 4

Studies, page 5

  1. A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

    Part 1 of this study is an open-label, dose-escalation, and safety expansion study of an anti-LILRB2 / anti-PD-L1 bispecific antibody SPX- 303 in patients with solid tumors. Part 2 of this study is an indication-specific dose expansion study of SPX-303.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic Arizona, Phoenix, Arizona
    Locations
    4 in total
    Run by
    SparX Biotech(Jiangsu) Co., Ltd.

    See if you can join NCT06259552 on ClinicalTrials.gov

  2. A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

    The goal of this open-label, dose escalation and dose expansion Phase I clinical trial is to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of BGC515 administered once daily in 3 weeks cycles in solid tumor patients.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    MD Anderson Cancer Center, Houston, Texas
    Run by
    BridGene Biosciences Inc.

    See if you can join NCT06452160 on ClinicalTrials.gov

  3. Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

    Goal: learn about QN-302 in patients with solid tumors (metastatic, or advanced cancer). Main questions: * What does the study drug do to human body (Pharmacodynamics [='PD']) * What does the body do to study drug (how processed in body (Pharmacokinetics [='PK']) - Safety Study drug by intravenous …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    HonorHealth, Scottsdale, Arizona
    Locations
    4 in total
    Run by
    Qualigen Theraputics, Inc.

    See if you can join NCT06086522 on ClinicalTrials.gov

  4. Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

    Most pediatric patients with solid tumors respond to initial high-dose, intensive therapy and complete treatment in remission. High-risk patients however, frequently have recurrent disease which is then treated with ad hoc regimens or early phase therapies with little benefit to the patient. Metron…

    Stage
    EARLY_Phase 1
    Ages
    1 to 31
    Site
    Miller Children's and Women's Hospital Long Beach, Long Beach, California
    Locations
    2 in total
    Run by
    Miller Children's & Women's Hospital Long Beach

    See if you can join NCT02446431 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.